Neuromend Infusions Schedule Free Consultation
New call-to-action
7 min read

Is Ketamine Effective for Treatment-Resistant Depression?

Jul 31, 2023 2:25:43 PM

For more information on the benefits and risks of ketamine, check out Andrew Huberman's latest podcast to learn more.

Treatment-resistant depression is a severe and debilitating condition that affects millions of people worldwide. Those with depression are roughly three times more likely than the general population to commit violent crimes. Traditional antidepressant medications and therapies may not always provide relief for these individuals, leading researchers and healthcare providers to explore alternative treatments. One such treatment that has gained attention is ketamine.

In this blog, we will dive into the efficacy and safety of ketamine for treatment-resistant depression.

  1. Understanding Treatment-Resistant Depression
  2. The KADS Study: Efficacy and Safety of Ketamine
  3. Results of the KADS Study
  4. Benefits of Using Ketamine to Treat Depression
  5. Insurance Coverage for Ketamine Treatments

Female patient holding bottle of medicine consulting with healthcare physician

Understanding Treatment-Resistant Depression

Before we delve into ketamine's potential as a treatment, it's essential to understand what treatment-resistant depression entails. Treatment-resistant depression refers to depression that does not respond adequately to multiple courses of standard antidepressant medications. Patients with TRD often experience persistent symptoms, making it challenging to achieve remission and maintain a good quality of life.

The KADS Study: Efficacy and Safety of Ketamine

One study that explored the efficacy and safety of ketamine for treatment-resistant depression was the KADS (Ketamine for Adult Depression) study. This specific KADS study out of Australia was a randomized, double-blind, active-controlled trial that investigated the effects of a four-week course of repeated subcutaneous ketamine injections in TRD patients.

Results of the KADS Study

Results from the KADS study deliver promising news for those suffering from treatment-resistant depression. The study found that a low-cost variant of ketamine showed incredible outcomes, with 20 percent of patients experiencing complete remission. What sets this study apart is that the generic form of ketamine used outperformed the placebo by an astounding 10-fold. And here's the clincher - the cost of this variant is more than 150 times less than the commonly administered S-ketamine used in clinics. These findings offer hope for individuals seeking urgent relief from TRD in a relatively short period.

Benefits of Using Ketamine to Treat Depression

Ketamine has shown potential in treating treatment-resistant depression. Unlike traditional antidepressants, which typically take weeks to show effects, ketamine can produce rapid antidepressant effects, often within hours or days after administration. This rapid onset of action has sparked interest in ketamine IV therapy as a potential game-changer for TRD patients.

Insurance Coverage for Ketamine Treatment

It is essential to address the issue of insurance coverage for ketamine treatment. Insurance coverage for ketamine treatment varies depending on the individual's insurance plan and location. While some insurance providers may cover ketamine treatment for treatment-resistant depression, others might not include it in their coverage. Patients interested in exploring ketamine treatment should check with their insurance provider to understand the extent of their coverage.

Ask NeuroMend about Ketamine Treatments

Ketamine shows significant potential as an effective and rapid-acting treatment for individuals struggling with treatment-resistant depression. The results from the KADS study are promising, indicating that repeated subcutaneous ketamine injections can lead to substantial improvements in depressive symptoms.

However, as with any medical treatment, it is crucial to consult with a healthcare provider and consider individual circumstances, potential side effects, and insurance coverage before pursuing ketamine therapy for treatment-resistant depression.

Our experienced staff at NeuroMend can answer any questions you may have regarding ketamine and treatment-resistant depression.

Contact us today to learn more!

New call-to-action

Reference: Cambridge University Press


neuromendicon2We are an Evidence-Based Center of Excellence and the leading provider of Ketamine Infusions, IV Infusions and Ketamine Consulting Services for Ketamine Clinics and IV Therapy Clinics.

We Provide Effective Treatment For The Following Conditions: Major Depressive Disorders, Post-traumatic Stress Disorder (PTSD), Bipolar Depression, Obsessive Compulsive Disorder (OCD), Chronic Migraines, Severe Anxiety, Fibromyalgia and Chronic Pain Syndrome.

Ask about NAD+ infusions for relief from the multitude of changes associated with age, age-related diseases, PTSD and chronic fatigue.

Learn more about Hormone Replacement Therapy and Semaglutide for weight loss. Check out our partner Drip IV who offers Semaglutide in Lafayette and Baton Rouge, LA.

Neuromend Team

Written by Neuromend Team

9 min read
Ketamine: A More Comfortable Alternative to Spinal Stimulators

Ketamine infusion therapy, in addition to helping with depression, is becoming a more common treatment for chronic pain, as it is seen as a more...

8 min read
Is Ketamine Treatment Covered By Health Insurance?

With many patients hearing about the success that Ketamine (through both IV treatments or assisted psychotherapy) is having on Treatment Resistant...

9 min read
Everything You Need to Know to Start a Ketamine Clinic

The demand for ketamine infusion therapy is growing at an exponential rate. As the mounting research supports the use of ketamine infusions for...

Care Credit Financing | Neuromend Infusion Center

How Ketamine Relieves Depression | Neuromend Infusion Center